December 4, 2014

Mylan on Thursday announced that its subsidiary, Mylan Labs, was granted tentative approval from the Food and Drug Administration for two dosages of abacavir/lamivudine tablets for oral suspension. 

December 4, 2014

Diplomat Pharmacy announced Wednesday that it has been selected to Pfizer's limited-distribution panel for Xalkori, Bosulif, Inlyta and Sutent.

December 2, 2014

Ranbaxy Laboratories on Monday announced the launch of Infimab (BOW015), the first Remicade (Infliximab) biosimilar in India. The product was launched at the Indian Rheumatology Association Conference in Chandigarh.

November 26, 2014

Just 30% of Americans with HIV had the virus under control in 2011, and approximately two-thirds of those whose virus was out of control had been diagnosed but were no longer in care.

November 24, 2014

Omnicare and McKesson on Monday announced the signing of an expanded agreement to include the sourcing and distribution of branded, specialty and generic pharmaceuticals. 

November 20, 2014

Decision Resources Group found that sales of biosimilar versions of the granulocyte colony-stimulating factors (G-CSFs) filgrastim and pegfilgrastim could reach $1.8 billion in the United States by 2023. 

November 20, 2014

More specialty drug innovation, greater patient access to medicines and reduced impact from patent expiries will be the primary drivers of an increase in global medicine spending of up to 30% by 2018.

November 17, 2014

Genzyme, a Sanofi company, on Friday announced that the Food and Drug Administration approved Lemtrada (alemtuzumab) for the treatment of patients with relapsing forms of multiple sclerosis. 

November 17, 2014

Pharmaceutical sales through HDMA-member traditional primary distributors reached nearly $305 billion in 2013.

November 14, 2014

Walgreens earlier this week opened its first Walgreens Specialty Pharmacy in the Omaha, Neb. market.

 

November 13, 2014

 Janssen Pharmaceuticals announced that the Food and Drug Administration approved the company's supplemental new drug application for the once-monthly Invega Sustenna (paliperidone palmitate), an antipsychotic used to treat schizoaffective disorder as either monotherapy or adjunctive therapy. 

November 11, 2014

UCB, Advent International and Avista Capital Partners last week announced they have entered into a definitive agreement providing for the acquisition of UCB’s U.S. specialty generics subsidiary, Kremers Urban Pharmaceuticals, by Advent and Avista.

November 6, 2014

Diplomat Pharmacy on Wednesday announced the addition of Martino Luu to their senior leadership team as VP innovation and process improvement.

 

November 4, 2014

Tailwinds from specialty pharmacy and increased generic utilization lifted CVS Health up on Tuesday, as the company posted net revenues of $35 billion, representing an increase of 9.7% for the three months ended Sept. 30.

 

November 3, 2014

The RAND Corp. projected that the introduction of biosimilar drugs in the United States will reduce direct spending on biologics by $44.2 billion from 2014 to 2024.

 

October 31, 2014

Mylan on Friday announced the launch of nevirapine extended-release tablets in 400-mg strength, a generic version of Viramune XR from Boehringer Ingelheim. 

October 30, 2014

Sandoz, through its branded dermatology business PharmaDerm, and Medigene AG on Thursday announced a promotion agreement with Women's Choice Pharmaceuticals for Veregen (sinecatechins) ointment, 15% strength. 

October 29, 2014

The majority of independent community pharmacists are interested in incorporating personalized medicine services into their practices, but they require further education before this is possible.

October 28, 2014

he Food and Drug Administration last week announced approval for Obizur for the treatment of bleeding episodes in adults with acquired hemophilia A. 

October 28, 2014

From Oct. 27 through Nov. 1, 2014, more than 11,000 McKesson employees at more than 170 locations across the United States will participate in the 16th Community Days program.

October 28, 2014

Onco360, one of the nation’s largest independent providers of oncology pharmacy services, on Monday announced that Paul Jardina was named president and CEO.

October 27, 2014

Burmans, an independent community pharmacy, was announced as a winner of the Patient Safety Award at the annual Innovation Awards presented by Philadelphia Business Journal and UnitedHealthcare.

October 24, 2014

In the wake of an Oct. 21 blogpost on Health Affairs, “The $500 Billion Medicare Slowdown: A Story About Part D,” Ralph Neas, president and CEO of the Generic Pharmacuetical Association, issued the following statement.

October 24, 2014

Pfizer on Thursday announced that the U.S. District Court for the District of Delaware upheld its basic patent and the L-malate salt patent covering Sutent (sunitinib malate) capsules.